Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top

Digestive Diseases and Sciences

Issue 5/2016

Special Issue: NAFLD and NASH

Content (19 Articles)

Editorial

Editors’ Introduction to the NAFLD and NASH Special Issue

Michael Fuchs, Bernd Schnabl

Review

Global Epidemiology of Nonalcoholic Fatty Liver Disease and Perspectives on US Minority Populations

Zaki A. Sherif, Armana Saeed, Shima Ghavimi, Seyed-Mehdi Nouraie, Adeyinka O. Laiyemo, Hassan Brim, Hassan Ashktorab

Review

Natural History of Nonalcoholic Fatty Liver Disease

George Boon-Bee Goh, Arthur J. McCullough

Review

Hepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLD

Helen L. Reeves, Marco Y. W. Zaki, Christopher P. Day

Review

Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease

Alessandro Mantovani, Stefano Ballestri, Amedeo Lonardo, Giovanni Targher

Review

Gut Microbiota of Nonalcoholic Fatty Liver Disease

Reham M. Abdou, Lixin Zhu, Robert D. Baker, Susan S. Baker

Review

Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease

Samir Softic, David E. Cohen, C. Ronald Kahn

Review

Innate Immunity and Inflammation in NAFLD/NASH

Marco Arrese, Daniel Cabrera, Alexis M. Kalergis, Ariel E. Feldstein

Review Article

Function of Autophagy in Nonalcoholic Fatty Liver Disease

Mark J. Czaja

Review

Role of MicroRNAs in NAFLD/NASH

Gyongyi Szabo, Timea Csak

Review

Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and Inflame

Samar H. Ibrahim, Petra Hirsova, Harmeet Malhi, Gregory J. Gores

Review

Quantitative Imaging Biomarkers of NAFLD

Sonja Kinner, Scott B. Reeder, Takeshi Yokoo

Review

Histological Assessment of NAFLD

Pierre Bedossa

Review

Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016

Dharmesh H. Kaswala, Michelle Lai, Nezam H. Afdhal

Review

Lifestyle and Dietary Interventions in the Management of Nonalcoholic Fatty Liver Disease

William N. Hannah Jr., Stephen A. Harrison

Review

Lifestyle Interventions Including Nutrition, Exercise, and Supplements for Nonalcoholic Fatty Liver Disease in Children

Jonathan A. Africa, Kimberly P. Newton, Jeffrey B. Schwimmer

Review

Medical and Surgical Treatment Options for Nonalcoholic Steatohepatitis

Kathleen E. Corey, Mary E. Rinella

Review

Novel Pharmacotherapy Options for NASH

Vlad Ratziu

Review

Nonalcoholic Fatty Liver Disease: Key Considerations Before and After Liver Transplantation

Yuval A. Patel, Carl L. Berg, Cynthia A. Moylan

Apr 16
Issue: 4/2016
Jun 16
Issue: 6/2016

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits